Market, Research, Report, Business, Industry, Information, Automotive, Banking, Finance, Food, Beverages, Technology, Biomass, Books, Conference, Company Profiles, Country

 
 
  
    Your Comprehensive Resource
 For Market Research

   
   
 Home  Contact us

 Login



Search for Industry Sector, Market Sector, Company Profiles

  

   

        

 Follow Us !!!

 
 
   

Aurobindo Pharma Ltd - Financial Analysis Review

Published Date : 28 January 2010
Pages : 19
 Add to Cart - Aurobindo Pharma Ltd - Financial Analysis Review 
 
Aurobindo Pharma Ltd - Financial Analysis Review
 
 Summary
 
 Aurobindo Pharma Limited (Aurobindo Pharma) is a pharmaceutical company. The company engages in manufacturing active pharmaceutical ingredients (APIs), intermediates and generic formulations. The product portfolio encompasses of 250 finished dosage formulations and 200 API with diversified products. Aurobindo Pharma offers products for the treatment of cardio vascular, central nervous system, anti-retroviral, gastro-intestinal, anti-infective, pain management and osteoporosis. The company has received approvals for both API and formulation facilities from regulatory agencies such as UKMHRA, WHO, Health Canada, MCC South Africa, USFDA and ANVISA-Brazil.
 
 "Aurobindo Pharma Ltd - Financial Analysis Review” is an in-depth business and financial analysis of Aurobindo Pharma Ltd. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
 
 And More inside the report…
 
 Recent Developments
 
 Dec 17, 2009: Aurobindo Pharma Receives FDA Approval For Cetirizine Hydrochloride Syrup
 Nov 27, 2009: Pfizer Hopes On Indian Pharma Company
 Nov 23, 2009: Aurobindo Pharma Inaugurates Manufacturing Facility In Hyderabad, India
 
 Scope
 
 - Provides key company information for business intelligence needs
 - The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
 - The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
 - Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
 
 Reasons to buy
 
 - A quick “one-stop-shop” to understand the company.
 - Enhance business/sales activities by understanding customers’ businesses better.
 - Get detailed information and financial analysis on companies operating in your industry.
 - Identify prospective partners and suppliers – with key data on their businesses and locations.
 - Compare your company’s financial trends with those of your peers / competitors.
 - Scout for potential acquisition targets, with insight into the companies’ financial performance.
 

Table of Contents :

 

  2
 List of Tables 2
 List of Figures 2
 Aurobindo Pharma Ltd - Key Facts 3
 Aurobindo Pharma Ltd - Business Description 3
 Aurobindo Pharma Ltd - Major Products and Services 4
 Aurobindo Pharma Ltd - History 5
 Aurobindo Pharma Ltd - Key Competitors 6
 Aurobindo Pharma Ltd - Key Employees 6
 Aurobindo Pharma Ltd - Key Employee Biographies 6
 Aurobindo Pharma Ltd - Company Statement 7
 Aurobindo Pharma Ltd - Locations And Subsidiaries 8
 Head Office 8
 Other Locations & Subsidiaries 8
 Aurobindo Pharma Ltd - Financial Ratios 10
 Financial Ratios - Capital Market Ratios 10
 Financial Ratios - Annual Ratios 10
 Financial Ratios - Interim Ratios 11
 Financial Ratios - Ratio Charts 12
 Recent Developments 13
 Jul 10, 2009: Aurobindo Receives Approval For Fosinopril Sodium, Hydrochlorothiazide Tablets 13
 Jul 24, 2009: Aurobindo Receives Approval For Zidovudine, Lamivudine And Zidovudine Tablets 13
 Aug 17, 2009: Aurobindo To Acquire Trident Life Sciences 13
 Sep 07, 2009: Aurobindo Obtains Two Swissmedic Approval 14
 Sep 07, 2009: Aurobindo Obtains Final Approval For Risperidone Oral Solution 14
 Nov 06, 2009: Aurobindo Pharma Obtains Final Approval From FDA For Lamotrigine Tablets 14
 May 21, 2009: Aurobindo Pharma Expands Licensing And Supply Agreement With Pfizer 14
 Mar 03, 2009: APL Signs Licensing And Supply Agreement With Pfizer 15
 Appendix 16
 Methodology 16
 Ratio Definitions 16
 About Global Markets Direct 19
 Contact Us 19
 Disclaimer 19
 
 List of Tables
 Aurobindo Pharma Ltd, Key Facts 3
 Aurobindo Pharma Ltd, Major Products and Services 4
 Aurobindo Pharma Ltd, History 5
 Aurobindo Pharma Ltd, Key Employees 6
 Aurobindo Pharma Ltd, Key Employee Biographies 6
 Aurobindo Pharma Ltd, Subsidiaries
 
 List of Figures
 Aurobindo Pharma Ltd, Performance Chart (2005 - 2009) 1
 Aurobindo Pharma Ltd, Ratio Charts 12

 

Published By : Global Markets Direct

 


Related Keywords: Energy, Insurance, Financial, Company Profile, Industry Profile, Swot Analysis, Apparel, Consumer, Trade, Information technology, Food, Healthcare, Construction, Retail, Design,Oil and Gas, Solar, Miscellaneous, Business, Pharmaceuticals, Technology, Defense, Medical, Travel, Power, Metal
 

  

 


PDF Format Reports will be
delivered by email within
12 to 24 hours after placing
 the order (Mon-Fri IST)

Australia Research Reports
Brazil Research Reports
Asia Research Reports
China Research Reports
Canada Research Reports
Europe Research Reports
France Research Reports
Egypt Research Reports
Global Research Reports
Greece Research Reports
Germany Research Reports
Japan Research Reports
India Research Reports
Ireland Research Reports

Korea Research Reports
Mexico Research Reports

Maldives Research Reports
New Zealand Research Reports
Netherland Research Reports
Poland Research Reports
Russia Research Reports
South Africa Research Reports
Sri Lanka Research Reports

Singapore Research Reports
Switzerland Research Reports  
UK Research Reports
USA Research Reports

UAE Research Reports
Uruguay Research Reports

ExxonMobil Company Analysis
Toyota Motors Company Analysis
ConocoPhillips Company Analysis
Sinopec Company Analysis
Total S.A. Company Analysis
Verizon Company Analysis
Gazprom Company Analysis
JPMorgan Company Analysis
Chevron Company Analysis
E.ON Company Analysis
PetroChina
Company Analysis
Allianz Company Analysis
AXA Company Analysis
Carrefour
Company Analysis
General Electric Company Analysis
Bank of America Company
Assicurazioni Generali Company
Samsung Electronics Company
GDF Suez Company Analysis
McKesson Corporation Company
Volkswagen Group Company
Royal Dutch Shell Company
 


 

 
 

Privacy Policy | Help/FAQ | Disclaimer | Sitemap | Resources | Research Blog | Feeds |  

Copyright © 2008 - 2012  trademark registered in India. All rights reserved.
Office Phone: (+91)
2227453309 | Telefax No: (+91) 2224169996
24/7 Online Support: (+91) 8149 85 2585 | Publishers contact: (+91) 8080 85 2585
Office Hours: 10:00 am to 6:00 pm (IST) Monday to Saturday

Email:
contact@aarkstore.com / customersupport@aarkstore.com